JAK3 pathway is constitutively active in B-lineage acute lymphoblastic leukemia

Gene expression profiles of infant acute lymphoblastic leukaemia and its prognostically distinct subsets

(2010) Sanjive Qazi et al.   BRITISH JOURNAL OF HAEMATOLOGY

BCL6 is critical for the development of a diverse primary B cell repertoire

(2010) Cihangir Duy et al.   JOURNAL OF EXPERIMENTAL MEDICINE

NF-κB/STAT3/PI3K signaling crosstalk in iMycEμ B lymphoma

(2010) Seong-Su Han et al.   Molecular Cancer

Array-based genomic resequencing of human leukemia

(2010) Y Yamashita et al.   ONCOGENE

CD22 EXON 12 deletion as a pathogenic mechanism of human B-precursor leukemia

(2010) F. M. Uckun et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IL-21 Contributes to JAK3/STAT3 Activation and Promotes Cell Growth in ALK-Positive Anaplastic Large Cell Lymphoma

(2009) Jennifer Dien Bard et al.   AMERICAN JOURNAL OF PATHOLOGY

Constitutive JAK3 activation induces lymphoproliferative syndromes in murine bone marrow transplantation models

(2009) M. G. Cornejo et al.   BLOOD

CXCR4 mediates the homing of B cell progenitor acute lymphoblastic leukaemia cells to the bone marrow via activation of p38MAPK

(2009) Julius G. Juarez et al.   BRITISH JOURNAL OF HAEMATOLOGY

JAK3: A two-faced player in hematological disorders

(2009) Melanie G. Cornejo et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Acute Lymphoblastic Leukemia-associated JAK1 Mutants Activate the Janus Kinase/STAT Pathway via Interleukin-9 Receptor α Homodimers

(2009) Tekla Hornakova et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Role of STAT5 in controlling cell survival and immunoglobulin gene recombination during pro-B cell development

(2009) Stephen Malin et al.   NATURE IMMUNOLOGY

JAK mutations in high-risk childhood acute lymphoblastic leukemia

(2009) C. G. Mullighan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Receptor expression is essential for proliferation induced by dimerized Jak kinases

(2008) Hodaka Fujii   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

BLNK suppresses pre-B-cell leukemogenesis through inhibition of JAK3

(2008) J. Nakayama et al.   BLOOD

Activating mutations in human acute megakaryoblastic leukemia

(2008) S. Malinge et al.   BLOOD

Functional analysis of JAK3 mutations in transient myeloproliferative disorder and acute megakaryoblastic leukaemia accompanying Down syndrome

(2008) Tomohiko Sato et al.   BRITISH JOURNAL OF HAEMATOLOGY

Somatic Mutations of JAK1 and JAK3 in Acute Leukemias and Solid Cancers

(2008) E. G. Jeong et al.   CLINICAL CANCER RESEARCH

The many faces of the SOCS box

(2008) Julie Piessevaux et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Ligand-independent Homomeric and Heteromeric Complexes between Interleukin-2 or -9 Receptor Subunits and the γ Chain

(2008) Yaniv Malka et al.   JOURNAL OF BIOLOGICAL CHEMISTRY